Luye Pharma Well Positioned for CNS Market with the Approval of A New Indication for Seroquel XR in China

Life Science

BeiGene Shows Off Strong Results from Checkpoint Inhibitor While Eying Potential Approval for BTK Inhibitor

Life Science

Long Hill Capital Closes $265 Million Second Fund for China Health Investments

Life Science

Etihad Partners Jiangsu Investment Firm to Aid Development of Abu Dhabi Aviation Park

Technology

Kolon Life Science to Export $207 Million of Gene Therapy Treatment to China’s Hainan Province

Life Science

Shanghai Fosun Pharma Considering $500 Million IPO of Gland Pharma

Life Science

China Unicom Opens Branch in South Africa to Tap Telecom Opportunities

Technology

UAE’s Largest Free Trade Zone Supports China’s Belt and Road Initiative

Technology

Shanghai Pharmas Form Union to Fix Short Supply of Drugs for Rare Diseases

Life Science

Takeda Eyes China Drug Market as its Next Big Opportunity Following Shire Deal

Life Science

Shuwen Biotech’s Clinical Lab Successfully Passes Biyearly College of American Pathologists Audit

Life Science

Tianjin Tasly in $24 Million Deal for EA Pharma Kidney Disease Drug

Life Science

Ascletis’ Hong Kong IPO to Raise $457 Million at $2 Billion Valuation

Life Science

Didi, SoftBank to Offer Taxi Hailing in Japan, Help Rising Number of Chinese Tourists

Technology

Aphria announces proposed acquisitions in Latin America, Jamaica worth around $200 million

Cannabis, Life Science